CHRONIC CONDITIONS - AN OVERVIEW

Dependant on the outcome of SURMOUNT-one trial, Zepbound® is one of the simplest weight loss drugs available. Provided that it has two unique mechanisms of action, it seems to have a more substantial impact on weight and blood sugar than GLP-1 agonist drugs alone, such as semaglutide or liraglutide, that happen to be both at this time FDA-approved